Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

被引：0
|
作者：
George J. Netto
机构：
[1] James Buchanan Brady Urological Institute,Departments of Pathology and Radiology
[2] Johns Hopkins University,undefined
来源：
Nature Reviews Urology | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Molecular biomarkers have been largely excluded from current management algorithms for urologic malignancies. This Review focuses on molecular biomarkers that could potentially be used to diagnose and prognose patients with bladder cancer, as well as markers with potential for forecasting and stratifying responses to emerging targeted therapies.
引用
收藏
页码：41 / 51
页数：10
相关论文
共 50 条
  • [1] Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
    Netto, George J.
    [J]. NATURE REVIEWS UROLOGY, 2012, 9 (01) : 41 - 51
  • [2] Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder
    Sapre, Nikhil
    Herle, Praduymna
    Anderson, Paul D.
    Corcoran, Niall M.
    Hovens, Christopher M.
    [J]. PATHOLOGY, 2014, 46 (04) : 274 - 282
  • [3] Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use
    Bolenz, Christian
    Lotan, Yair
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (12): : 676 - 685
  • [4] Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use
    Christian Bolenz
    Yair Lotan
    [J]. Nature Clinical Practice Urology, 2008, 5 : 676 - 685
  • [5] Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
    Akhtar, Mohammed
    Al-Bozom, Issam A.
    Ben Gashir, Mohamed
    Taha, Noheir M.
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (04) : 251 - 256
  • [6] The current status of molecular biomarkers in patients with metastatic urothelial carcinoma of the bladder
    Kerr, Preston S.
    Freedland, Stephen J.
    Williams, Stephen B.
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (02) : 127 - 129
  • [7] Molecular biomarkers in urothelial bladder cancer
    Kim, Wun-Jae
    Bae, Suk-Chul
    [J]. CANCER SCIENCE, 2008, 99 (04): : 646 - 652
  • [8] Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder
    Laukhtina, Ekaterina
    Pradere, Benjamin
    Lemberger, Ursula
    Karakiewicz, Pierre I.
    Fajkovic, Harun
    Shariat, Shahrokh F.
    [J]. CURRENT OPINION IN UROLOGY, 2022, 32 (05) : 561 - 566
  • [9] Biomarkers for platinum sensitivity in bladder cancer: are we there yet?
    Singla, Nirmish
    Ghandour, Rashed A.
    Raj, Ganesh V.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S236 - S239
  • [10] Biomarkers in renal cell carcinoma: Are we there yet?
    Gulati, Shuchi
    Vogelzang, Nicholas J.
    [J]. ASIAN JOURNAL OF UROLOGY, 2021, 8 (04) : 362 - 375
12345